Stock PTCT PTC THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News PTC Therapeutics, Inc.

Equities

PTCT

US69366J2006

Real-time Estimate Cboe BZX
Other stock markets
 03:41:32 2024-04-26 pm EDT 		5-day change 1st Jan Change
28.32 USD +11.12% Intraday chart for PTC Therapeutics, Inc. +11.91% +2.81%
09:32pm Sector Update: Health Care MT
05:24pm PTC Therapeutics Shares Rise After Better-Than-Expected Q1 Results MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Sector Update: Health Care
MT
PTC Therapeutics Shares Rise After Better-Than-Expected Q1 Results
MT
PTC Therapeutics : Q1 2024 FLS
PU
PTC Therapeutics: Q1 Earnings Snapshot
AQ
Earnings Flash (PTCT) PTC THERAPEUTICS Posts Q1 Revenue $210.1M, vs. Street Est of $163.8M
MT
PTC Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Transcript : PTC Therapeutics, Inc., Q1 2024 Earnings Call, Apr 25, 2024
PTC Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
PR
PTC Therapeutics, Inc. Provides Earnings Guidance for the Year 2024
CI
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(4)
AQ
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR
PTC Therapeutics to Host Conference Call to Discuss First Quarter 2024 Financial Results
AQ
PTC Therapeutics to Host Conference Call to Discuss First Quarter 2024 Financial Results
PR
PTC Therapeutics Seeks EMA Marketing Authorization for Sepiapterin for Phenylketonuria Treatment
MT
PTC Announces Submission of Sepiapterin MAA for Treatment of PKU to EMA
PR
PTC Therapeutics, Inc. Announces Submission of Sepiapterin MAA for Treatment of PKU to EMA
CI
ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza as a Treatment for AADC Deficiency
AQ
ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza? as a Treatment for AADC Deficiency
CI
PTC Therapeutics Provides Key Regulatory Updates
PR
Transcript : PTC Therapeutics, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 04:05 PM
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PTCT Stock
  4. News PTC Therapeutics, Inc.